Mason & Associates (California)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Mason & Associates (California)'s MRK Position: Q1 2025 in Review
Mason & Associates (California) sold out of Merck (MRK) in Q1 2025, closing a stake of 2,107 shares — an estimated $210K sold.
Mason & Associates (California) first reported a position in MRK in Q2 2023 and held it in 6 quarters. The position peaked at $268K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Mason & Associates (California) reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
- Mason & Associates (California) sold 2,107 Merck shares in Q1 2025, an estimated $210K.
- Mason & Associates (California) first reported a position in Merck in Q2 2023 and held it in 6 quarters.
- Mason & Associates (California)'s Merck position peaked at $268K in Q1 2024.
- 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Mason & Associates (California)'s 13F filing for Q1 2025, filed 17 Apr 2025.